Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "IDA"

1727 News Found

Vijaya Diagnostic Centre reports Q1 FY25 consolidated PAT at Rs. 31.34 Cr
News | August 06, 2024

Vijaya Diagnostic Centre reports Q1 FY25 consolidated PAT at Rs. 31.34 Cr

Vijaya Diagnostic Centre has reported total income of Rs. 159.78 crores during the quarter ended June 30, 2024


SMS Pharmaceuticals reports Q1 FY25 consolidated PAT at Rs. 16.48 Cr
News | August 06, 2024

SMS Pharmaceuticals reports Q1 FY25 consolidated PAT at Rs. 16.48 Cr

SMS Pharmaceuticals has reported total income of Rs. 165.81 crores during the quarter ended June 30, 2024


Divis Laboratories reports Q1 FY25 consolidated PAT at Rs. 430 Cr
News | August 05, 2024

Divis Laboratories reports Q1 FY25 consolidated PAT at Rs. 430 Cr

Divis Laboratories has reported total income of Rs. 2,197 crores during the period ended June 30, 2024


Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr
News | August 02, 2024

Dabur Q1 FY25 consolidated net profit up 8% at Rs 500 Cr

Q1 Consolidated operating profit Up 8.3%; revenue grows 7% to Rs 3,349 crore


Sun Pharma posts Q1 FY25 consolidated PAT at Rs. 2,835.62 Cr
News | August 02, 2024

Sun Pharma posts Q1 FY25 consolidated PAT at Rs. 2,835.62 Cr

Sun Pharmaceutical Industries has reported total income of Rs. 13,185.30 crores during the period ended June 30, 2024


Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr
News | August 01, 2024

Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr

Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024


Themis Medicare posts Q1 FY25 consolidated PAT higher at Rs. 24.68 Cr
News | July 31, 2024

Themis Medicare posts Q1 FY25 consolidated PAT higher at Rs. 24.68 Cr

Themis Medicare has reported total income of Rs. 123.95 crores during the period ended June 30, 2024


Granules India posts Q1 FY25 consolidated PAT higher at Rs. 134.64 Cr
News | July 31, 2024

Granules India posts Q1 FY25 consolidated PAT higher at Rs. 134.64 Cr

Granules India has reported total income of Rs. 1181.92 crores during the period ended June 30, 2024


Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr
News | July 29, 2024

Dr Reddys Laboratories posts Q1 FY25 consolidated PAT at Rs. 1,392 Cr

Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024


Pfizer announces positive topline results from Phase 3 study of hemophilia A gene therapy candidate
Diagnostic Center | July 26, 2024

Pfizer announces positive topline results from Phase 3 study of hemophilia A gene therapy candidate

Giroctocogene fitelparvovec study meets primary and key secondary objectives of superiority compared to prophylaxis